Open AccessInterclass Difference in Pneumonia Risk in COPD Patients Initiating Fixed Dose Inhaled Treatment Containing Extrafine Particle Beclometasone versus Fine Particle Fluticasone [Corrigendum]
Author(s) -
David Price,
William Henley,
José Eduardo Delfini Cançado,
Leonardo M. Fabbri,
Huib A. M. Kerstjens,
Alberto Papi,
N. Roche,
Elif Şen,
Dave Singh,
Claus Vogelmeier,
Sara Barille,
Eleudo,
Victoria Carter,
Derek Skinner,
Rebecca Vella,
George Georges
Publication year - 2022
Publication title -
international journal of chronic obstructive pulmonary disease/international journal of copd
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.394
H-Index - 67
eISSN - 1178-2005
pISSN - 1176-9106
DOI - 10.2147/copd.s363875
Subject(s) - medicine , fluticasone , copd , inhalation , pneumonia , fluticasone propionate , beclometasone dipropionate , anesthesia , lung , respiratory disease